IT
Imarx Therapeutics Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Takats Joseph Richard, was filed 02 Jun 2010.
Imarx Therapeutics Inc: what insiders have been doing
This page follows insider dealings at Imarx Therapeutics Inc as filed with SEC (Form 4). No insider at Imarx Therapeutics Inc has published a filing in the past twelve months. The most recent one dates from 2 June 2010.
Over the whole record (from 2007), the tally stands at 9 purchases and 4 sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
28
Thresholds
n/a
Buy Volume
€306,291
9 ops. · all time
Sell Volume
€280,112
4 ops. · all time
Last declaration on 2 June 2010
Declarations28 total
- 25,542,784 shares@ US$0.0078Common StockSEC:0001127855-10-000209:0Canonical exit: 26 Aug 2010 (T+90)
- 0$200,000 Promissory NoteSEC:0001127855-10-000209:1
- 0$200,000 Promissory NoteSEC:0001127855-10-000208:1
- 37,905 shares@ US$0.0165Common StockSEC:0000893877-10-000240:0
- 300,000 shares0Common StockSEC:0000893877-09-000315:0
- 300,000 shares0Common StockSEC:0000893877-09-000313:0
- 300,000 shares0Common StockSEC:0000893877-09-000311:0
- 300,000 shares0Common StockSEC:0000893877-09-000314:0
- 300,000 shares0Common StockSEC:0000893877-09-000312:0
- 1,176,471 shares@ US$0.34Common StockSEC:0001225208-08-014960:0
- 23,810 shares0Common StockSEC:0001406497-08-000006:0
- 23,810 shares0Common StockSEC:0001406497-08-000004:0
- 23,810 shares0Common StockSEC:0001406497-08-000002:0
- 23,810 shares0Common StockSEC:0001406497-08-000003:0
- 23,810 shares0Common StockSEC:0001406497-08-000005:0
- 4,700 shares@ US$2.01Common StockSEC:0001123695-07-000003:0Canonical exit: 13 Mar 2008 (T+90)
- 5,000 shares@ US$2.20Common StockSEC:0001123695-07-000002:0Canonical exit: 9 Mar 2008 (T+90)
- 5,000 shares@ US$2.25Common StockSEC:0001406497-07-000016:0Canonical exit: 6 Mar 2008 (T+90)
- 1,905 shares@ US$2.23Common StockSEC:0001406497-07-000015:0Canonical exit: 3 Mar 2008 (T+90)
- 1,300 shares@ US$2.35Common StockSEC:0001406497-07-000014:0Canonical exit: 26 Feb 2008 (T+90)
- 11,388 sharesCommon StockSEC:0001406497-07-000001:0
- 10,025 sharesCommon StockSEC:0001406497-07-000001:1
- 57,205 sharesCommon StockSEC:0001406497-07-000002:1
- 15,000 shares@ US$5.00Common StockSEC:0001406497-07-000004:0
- 5,000 shares@ US$5.00Common StockSEC:0001406497-07-000005:0
25 of 28 declarations
About Imarx Therapeutics Inc
Imarx Therapeutics Inc is a biotechnology company focused on developing innovative therapies for the treatment of serious diseases. It is listed on NASDAQ under the ticker IMRX.
